DIGOXIN USE IN ATRIAL FIBRILLATION IS ASSOCIATED WITH INCREASED RISK OF MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORE THAN 200,000 PATIENTS

Waqas Qureshi; Zaid Alirhayim; Amjad Ahmed; Mouaz Al-Mallah; King AbdulAziz

doi:10.1016/S0735-1097(15)60289-3

Back

DIGOXIN USE IN ATRIAL FIBRILLATION IS ASSOCIATED WITH INCREASED RISK OF MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORE THAN 200,000 PATIENTS

Journal article

Peer reviewed

DIGOXIN USE IN ATRIAL FIBRILLATION IS ASSOCIATED WITH INCREASED RISK OF MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORE THAN 200,000 PATIENTS

Waqas Qureshi, Zaid Alirhayim, Amjad Ahmed, Mouaz Al-Mallah and King AbdulAziz

Journal of the American College of Cardiology, Vol.65(10), pp.A289-A289

17/03/2015

DOI: https://doi.org/10.1016/S0735-1097(15)60289-3

Abstract

Cardiac arrhythmia

Clinical trials

Confidence intervals

Drug therapy

Mortality

Studies

In a random effects model, digoxin was associated with increased risk of mortality in patients with AF (pooled hazard ratio 1.26; 95% CI 1.16 - 1.37, p <0.001).

Metrics

1 Record Views

Details

Title: DIGOXIN USE IN ATRIAL FIBRILLATION IS ASSOCIATED WITH INCREASED RISK OF MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORE THAN 200,000 PATIENTS
Creators - without role: Waqas Qureshi - Saudi Heart Association
Zaid Alirhayim - Saudi Heart Association
Amjad Ahmed - Saudi Heart Association
Mouaz Al-Mallah - Saudi Heart Association
King AbdulAziz - Saudi Heart Association
Publication Details: Journal of the American College of Cardiology, Vol.65(10), pp.A289-A289
Publisher: Elsevier Limited
Identifiers: 9920922808331
Language: English
Resource Type: Journal article